BPC-157 vs TB-500: Complete Research Comparison
BPC-157 vs TB-500: Complete Research Comparison
Two of the most studied peptides in recovery research. Both investigated for healing and tissue repair, but with different mechanisms and research applications. This guide breaks down the science to help researchers understand which compound fits their protocols.
Quick Overview
| BPC-157 | TB-500 | |
|---|---|---|
| Full Name | Body Protection Compound-157 | Thymosin Beta-4 (fragment) |
| Amino Acids | 15 (pentadecapeptide) | 43 (TB-4 is 43 AA; TB-500 is active fragment) |
| Source | Human gastric juice sequence | Thymus gland protein |
| Primary Research | Localized tissue repair, GI protection | Systemic healing, anti-inflammatory |
| Mechanism Focus | Angiogenesis, growth factor upregulation | Actin regulation, stem cell mobilization |
Mechanism of Action
BPC-157
- Angiogenesis: Stimulates VEGF and new blood vessel formation
- NO System: Modulates nitric oxide pathways
- Enthesis Healing: Documented efficacy at tendon-bone junctions
- GI Protection: Original discovery context — gastric mucosa defense
TB-500
- Actin Regulation: Upregulates cell-building protein
- Stem Cell Mobilization: Recruits repair cells to injury sites
- Anti-Inflammatory: Systemic reduction of inflammatory markers
- Cell Migration: Enhances cell movement to damaged tissue
Research Applications
BPC-157 Research Areas
- Tendon and ligament healing (Achilles, rotator cuff models)
- Gastric mucosa and gut lining integrity
- Muscle crush injury recovery
- Bone fracture healing acceleration
- Corneal and nerve tissue repair
TB-500 Research Areas
- Systemic anti-inflammatory protocols
- Soft tissue flexibility and recovery
- Wound healing (dermal models)
- Cardiac tissue repair studies
- Immune system modulation
Key Research Differences
Local vs Systemic: BPC-157 research typically focuses on specific tissue repair. TB-500 is studied for whole-body healing effects.
GI vs General: BPC-157 has extensive gastric research. TB-500 is not GI-specific.
Actin vs Growth Factors: TB-500 works through actin cytoskeleton. BPC-157 influences growth factor expression.
Synergistic Research: The Glow Stack
Many researchers investigate BPC-157 and TB-500 together:
- BPC-157 handles localized repair signaling
- TB-500 addresses systemic inflammation and stem cell recruitment
- Together they cover both local and systemic healing pathways
Our Glow Stack combines BPC-157, TB-500, and GHK-Cu for comprehensive recovery research.
Research Citations
BPC-157 Key Studies
- Sikiric P, et al. (1993). Digestive Diseases and Sciences — Original gastric protection discovery
- Krivic A, et al. (2006). Inflammation Research — Achilles tendon healing
- Chang CH, et al. (2011). Journal of Applied Physiology — Rotator cuff repair
TB-500 Key Studies
- Malinda KM, et al. (1999). International Journal of Molecular Medicine — Wound healing
- Evans M, et al. (2006). Journal of Investigative Dermatology — Dermal repair
Which for Your Research?
Choose BPC-157 if researching:
- Localized tendon/ligament healing
- Gastrointestinal protective effects
- Enthesis (tendon-to-bone) repair
- Muscle injury with localized focus
Choose TB-500 if researching:
- Systemic anti-inflammatory effects
- Whole-body recovery protocols
- Soft tissue flexibility
- Stem cell mobilization
Consider Both if: Comprehensive recovery research covering both local repair and systemic inflammation.
Product Specifications
| Product | Form | Purity | Storage |
|---|---|---|---|
| BPC-157 | Lyophilized powder | ≥98% | -20°C (frozen) |
| TB-500 | Lyophilized powder | ≥98% | -20°C (frozen) |
| Glow Stack | Combined formulation | ≥98% | -20°C (frozen) |
Reconstitution Notes
Both compounds require reconstitution with bacteriostatic water before research use. Use our peptide calculator for accurate mixing ratios.
Related Research
All products intended for research purposes only. Not for human consumption. Certificate of analysis available on request.